摘要
一种新型的房水引流装置Ex-press青光眼引流器植入术的实施,为青光眼术式带来了新选择。特别是为难治性青光眼患者带来更多希望。目前选定眼压控制不佳的前房较深青光眼患者作为该术式的最佳适应症已基本达成共识。另有研究表明巩膜瓣下Ex-Press青光眼引流器植入术联合抗代谢药物应用较单一行Ex-Press青光眼引流器植入术降眼压效果更为理想。在新生血管性青光眼患者联合术前应用血管内皮生长因子抑制剂治疗可使这种以往处理起来非常棘手的疾病明显提高手术成功率。用传统青光眼滤过手术与Ex-Press青光眼引流器植入术相比,后者操作简单,并发症少,降眼压效果确切。
A novel aqueous humor drainage device, Ex-press shunt brings new option for surgical treatment of glaucoma. In particular, it brings more hope to patients with refractory glaucoma. It reached a basic consensus that the glaucoma with deep anterior chamber and poor control of intraoeular pressures（IOP） was its best indication. Another study showed that Ex-press shunt implantation under the scleral flap combined application antimetabolites is more effective than simple implantation of Ex-press shunt on the IOP lowering effect.When it combined with vascular endothelial growth factor inhibitors preoperativly, the success rate can be improved significantly in patients with neovaseular glaucoma which is a kind of very tricky disease, Compared with traditional glaucoma filtration surgery, its operation is simple, but having fewer complications and exact effect of IOP.
出处
《中国城乡企业卫生》
2016年第9期57-59,共3页
Chinese Journal of Urban and Rural Enterprise Hygiene
